9V4-97234-85217
3 vaccinations
1 coded response
19 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 940 / CA
- Registered
- 2021-06-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-05-18
Dose 1 — Pfizer-BioNTech
-
2021-06-08
Dose 2 — Pfizer-BioNTech
-
2021-06-09
Registered in v-safe
- 2021-06-09
-
2021-06-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-06-13
- 2021-06-15
- 2021-06-22
- 2021-07-06
- 2021-07-14
- 2021-07-20
-
2021-09-07
Survey response — 3 months, dose 2MedDRA: Asthenia, Dyspnoea — Feeling: FairFree text: Shortest of breath WeaknessMedDRA releases: 2024-11 · check-in free text available
-
2022-01-15
Dose 3 — Pfizer-BioNTech
- 2022-01-16
- 2022-01-17
- 2022-01-18
- 2022-01-19
- 2022-01-20
- 2022-01-22
- 2022-01-29
- 2022-02-07
- 2022-02-19
- 2022-02-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-18 | Pfizer-BioNTech | |
| 2 | 2021-06-08 | Pfizer-BioNTech | |
| 3 | 2022-01-15 | Pfizer-BioNTech | No |
Free text
Release 9 — 3 months, dose 2
Symptoms: Shortest of breath Weakness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release